Andreas J R Habenicht Selected Research

LDL Lipoproteins (beta Lipoproteins)

2/2003

Expanding expression of the 5-lipoxygenase pathway within the arterial wall during human atherogenesis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Andreas J R Habenicht Research Topics

Disease

16	Atherosclerosis 01/2021 - 02/2003
6	Inflammation (Inflammations) 03/2019 - 02/2003
2	Atherosclerotic Plaque (Atheroma) 01/2021 - 01/2012
2	Pancreatic Neoplasms (Pancreatic Cancer) 11/2018 - 01/2018
2	Cardiovascular Diseases (Cardiovascular Disease) 04/2009 - 09/2004
2	Aortic Aneurysm (Aneurysm, Aortic) 11/2006 - 09/2004
2	Aneurysm (Aneurysms) 11/2006 - 09/2004
1	Disease Progression 01/2022
1	Alzheimer Disease (Alzheimer's Disease) 01/2019
1	Adenocarcinoma 01/2018
1	Neoplasms (Cancer) 01/2018
1	Autoimmune Diseases (Autoimmune Disease) 03/2010
1	Asthma (Bronchial Asthma) 04/2009
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2009
1	Hypersensitivity (Allergy) 05/2007
1	Down Syndrome Critical Region 04/2006
1	Vascular System Injuries 04/2006
1	Hyperlipidemias (Hyperlipidemia) 09/2004
1	Stroke (Strokes) 09/2004
1	Myocardial Infarction 09/2004

Drug/Important Bio-Agent (IBA)

9	Apolipoproteins E (ApoE)IBA 01/2021 - 11/2005
6	Arachidonate 5-Lipoxygenase (5 Lipoxygenase)IBA 04/2009 - 02/2003
5	ApolipoproteinsIBA 01/2021 - 09/2004
3	Proteins (Proteins, Gene)FDA Link 01/2019 - 09/2004
3	LipidsIBA 06/2016 - 09/2004
3	ChemokinesIBA 03/2010 - 09/2004
2	Adrenergic Agents (Adrenergic Drugs)IBA 11/2018 - 01/2018
2	Nerve Growth Factors (Neurotrophins)IBA 11/2018 - 01/2018
2	AutoantigensIBA 01/2016 - 05/2014
2	LeukotrienesIBA 04/2009 - 10/2003
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 11/2007 - 04/2006
2	CholatesIBA 11/2006 - 09/2004
1	Galectin 3 (LGALS3)IBA 01/2021
1	Complement System Proteins (Complement)IBA 01/2019
1	Protein Isoforms (Isoforms)IBA 01/2019
1	Small Interfering RNA (siRNA)IBA 01/2019
1	Nerve Growth Factor (NGF)IBA 01/2018
1	CatecholaminesIBA 01/2018
1	EnzymesIBA 01/2016
1	Lymphotoxin-alpha (Lymphotoxin)IBA 06/2015
1	AntigensIBA 01/2012
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 03/2010
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 03/2010
1	Messenger RNA (mRNA)IBA 01/2009
1	EicosanoidsIBA 11/2007
1	GlucocorticoidsIBA 05/2007
1	Adrenal Cortex Hormones (Corticosteroids)IBA 05/2007
1	Angiotensin IIIBA 11/2006
1	E-SelectinIBA 04/2006
1	Cycloheximide (Cicloheximide)IBA 04/2006
1	LigandsIBA 04/2006
1	Thrombin FDA Link 04/2006
1	Thromboplastin (Tissue Factor)IBA 04/2006
1	Transcription Factors (Transcription Factor)IBA 04/2006
1	Leukotriene D4IBA 04/2006
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 04/2006
1	DisintegrinsIBA 04/2006
1	ThrombospondinsIBA 04/2006
1	Metalloproteases (Metalloproteinases)IBA 04/2006
1	Chemokine CCL3IBA 11/2005
1	Biological ProductsIBA 09/2005
1	Matrix Metalloproteinase 2 (Gelatinase A)IBA 09/2004
1	5-Lipoxygenase-Activating ProteinsIBA 09/2004
1	Leukotriene Receptors (Leukotriene Receptor)IBA 08/2003
1	CalciumIBA 08/2003
1	LDL Lipoproteins (beta Lipoproteins)IBA 02/2003
1	Lipoxygenase (Lipoxygenase-1)IBA 02/2003
1	Arachidonate 15-Lipoxygenase (Arachidonate 15 Lipoxygenase)IBA 02/2003

Therapy/Procedure

1	Ganglionectomy 01/2022
1	Lasers (Laser) 01/2011